The Role of Probiotics in Preventing Recurrent Urinary Tract Infections in Pregnant Women
NCT ID: NCT06429358
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-06-23
2024-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotics on Recurrent Urinary Tract Infections
NCT06192966
Assess the Effects of a Limosilactobacillus Supplement on Recurrence of UTI in Healthy Women During a 6-month Period
NCT05793814
Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03644966
Lactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant Women
NCT03362697
Probiotics (Lactobacillus Rhamnosus) in Reducing Glucose Intolerance During and After Pregnancy
NCT01436448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic Group
The probiotic group received a daily oral supplement with Lactobacillus rhamnosus. The probiotic supplement was delivered as easy-to-swallow capsules.
Lactobacillus rhamnosus
The probiotic supplement was delivered in the form of easy-to-swallow capsules.
Control Group
Control Group
Participants in the control group were given a placebo that looked, tasted, and felt just like the probiotic pill.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactobacillus rhamnosus
The probiotic supplement was delivered in the form of easy-to-swallow capsules.
Control Group
Participants in the control group were given a placebo that looked, tasted, and felt just like the probiotic pill.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of recurrent urinary tract infections (two or more episodes in the past year).
* Singleton pregnancy.
Exclusion Criteria
* History of preterm labor.
* Chronic medical conditions (e.g., diabetes mellitus, immunodeficiency disorders).
* Use of antibiotics or probiotics within the past month.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frontier Medical and Dental College, Abbotabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Saif ur Rehman
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frontier Medical and Dental College
Abbottābād, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3388
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.